US IPO Pipeline SEC S-1 Filings — October 23, 2026

Nasdaq suspension effective May 14, 2026 after a delisting notice on May 7, 2026 and a missed 36-month business combination deadline from the May 4, 2023 IPO effective date; post-merger Nasdaq listing is not assured

Business Combination Agreement with Cartiga, LLC dated August 22, 2025 (approved by directors August 19, 2025) remains the only path to value, but no third-party valuation or fairness opinion was obtained

Resale registration of up to 105,223,881 shares at an assumed $0.5227 price (October 20, 2026 close) implies share count expansion of a size that could materially dilute existing holders

Company receives no proceeds from resales but may draw up to $100 million gross from future sales to the Selling Stockholder at its sole discretion, providing a potential funding backstop

S-1 filed October 23, 2026 ties the registration to the Armada Acquisition Corp. II business combination, Series C and Ripple Group subscription agreements, and XRP-denominated subscriptions dated October 19, 2025, indicating active capital raising around a digital-asset treasury thesis

A fairness opinion initial payment tied to the October 19, 2025 transaction suggests the board sought independent valuation support, a relative positive versus ALCY's lack of any fairness opinion

IPO closed May 22, 2025 with an over-allotment option and sponsor/non-managing investor private placement, a completed SPAC capitalization that has moved into a definitive business combination stage

Securities suspended from Nasdaq since May 14, 2026 and trading as ALCYF, ALCUF, and ALCWF on OTC Pink, reducing liquidity and institutional eligibility

Failure to complete a business combination within 36 months of the May 4, 2023 IPO effective date triggered the delisting process, a governance failure that can precede liquidation or redemption events

No third-party valuation or fairness opinion was obtained for the Cartiga transaction, leaving shareholders without independent support for the terms of a merger involving up to 3,659,056 Class A shares and 5,750,000 warrants

Nasdaq listing of the combined Cartiga Holdings, Inc. is explicitly not assured, so exit liquidity for post-merger holders is uncertain

Share issuance under the equity facility varies inversely with market price, so a further price decline would increase the number of shares issued per dollar raised, accelerating dilution

Stock trading below $1 exposes ONFO to Nasdaq minimum bid price deficiency procedures, a delisting risk compounding the dilution overhang

The Selling Stockholder may be deemed an underwriter under Section 2(a)(11) of the Securities Act, and resale of up to 105.2 million shares creates persistent supply pressure

The S-1 excerpt contains only XBRL tagging metadata with no narrative financials, so the size, valuation, and terms of the XRP-related subscriptions cannot be confirmed from the supplied content

XRP-linked subscription and token agreements introduce crypto price volatility and regulatory classification risk into the capital structure

S-1 registration and Series C and Ripple Group subscription agreements indicate committed institutional capital, a potential catalyst if the XRP treasury thesis executes and the registration proceeds on schedule

The fairness opinion engagement tied to the October 19, 2025 transaction offers independent valuation discipline absent from competing SPAC deals, a differentiator for investors weighing deal quality

With ALCY suspended and trading on OTC Pink, a pending Cartiga merger and warrant structure (5,750,000 warrants) could create mispricing for investors who can underwrite the redemption and merger outcome

The Delaware domestication and Up-C structure for Cartiga, LLC may preserve tax-advantaged economics for legacy LLC members, a structural feature worth diligence if the merger closes

The up-to-$100 million facility gives ONFO a committed funding source at the company's discretion, which if deployed prudently could fund growth without immediate new dilution beyond the facility terms

At $0.5227 per share, ONFO trades at a deep discount that could re-rate sharply on a successful financing or operational milestone, appealing to speculative capital that accepts the dilution risk

The ALCY case illustrates that 36-month business combination deadlines are binding, and SPACs that fail to close face Nasdaq delisting and migration to OTC markets, a pattern that will reduce the investable SPAC universe as legacy 2023-vintage vehicles expire [watch for similar delisting notices across the 2023 SPAC cohort]

Evernorth's XRP-linked subscriptions and the Armada II combination show crypto-treasury theses being packaged through SPAC and S-1 routes, implying that digital-asset exposure is a live driver of capital formation in 2025-2026 registrations

The ONFO S-1 resale of 105.2 million shares underscores a broader pattern of micro-cap companies using equity lines and resale registrations to fund operations, which typically precedes price pressure and reverse-split risk

ALCY obtained no fairness opinion while Evernorth engaged one, indicating a material governance split within the SPAC-to-public-company pipeline that investors can use to screen deal quality

Both ONFO's sub-$1 price and ALCY's suspension reflect listing-standard pressure on small issuers, suggesting elevated exchange delisting activity in the micro-cap segment during this period

Monitor S-4 effectiveness and shareholder meeting scheduling for the Cartiga business combination; any Nasdaq relisting application for Cartiga Holdings, Inc. is a key catalyst [date not supplied in filing excerpt]

Track shareholder redemption results and remaining trust cash at closing, as these determine the real float of the combined company [date not supplied]

Watch for closing of the Armada II business combination and funding of the Series C and Ripple Group subscriptions, which will confirm whether the XRP treasury capital is actually deployed [date not supplied]

Monitor SEC staff comments and the pricing range disclosure in the S-1 for valuation signals on the proposed offering [date not supplied]

A deficiency notice would follow sustained trading below $1; monitor for a notice and any reverse-split proposal [date not supplied]

Track sales to the Selling Stockholder under the April 10, 2026 facility, since each draw reveals the effective issuance price and cumulative dilution against the 105.2 million share resale ceiling [ongoing]

Monitor daily volume and any Form 4 or 144 filings tied to resale activity as an early indicator of supply pressure [ongoing]